Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income (loss) $ (8,096) $ (7,258)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 2,753 2,466
Amortization of debt issuance costs and discount 170 146
Equity-based compensation expense 2,535 1,958
(Gain) loss on change in fair value of committed equity facility 0 (106)
(Gain) loss on change in fair value of warrants 1,075 2,784
Deferred provision (benefit) for income taxes 98 (131)
Non-cash lease expense 12 26
Non-cash interest expense 0 384
Other 397 94
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 13,174 3,394
(Increase) decrease in contract assets (2,981) (9,423)
(Increase) decrease in inventory (100) 18
(Increase) decrease in prepaid insurance 396 827
(Increase) decrease in prepaid expenses and other assets 427 (183)
Increase (decrease) in accounts payable and accrued expenses 7,929 (3,627)
Increase (decrease) in deferred revenue (15,413) (4,844)
Increase (decrease) in operating lease liabilities (84) (39)
Increase (decrease) in other liabilities 472 23
Increase (decrease) in notes payable to sellers 0 (557)
Net cash provided by (used in) operating activities 2,764 (14,048)
Cash flows from investing activities:    
Purchases of property, plant and equipment, net (1,561) (787)
Purchase of intangible assets (806) (12)
Net cash provided by (used in) investing activities (2,367) (799)
Cash flows from financing activities:    
Proceeds received from debt 5,000 0
Repayments of debt (2,793) (1,094)
Repayment of finance leases (119) (77)
Payment of committed equity facility transaction costs 0 (571)
Payments of issuance costs related to convertible preferred stock 0 (52)
Shares repurchased for settlement of employee tax withholdings on share-based awards (56) 0
Payment of contingent earnout 0 (443)
Net cash provided by (used in) financing activities 2,032 (2,237)
Effect of foreign currency rate changes on cash and cash equivalents (138) 41
Net increase (decrease) in cash and cash equivalents 2,291 (17,043)
Cash and cash equivalents at beginning of period 30,278 28,316
Cash and cash equivalents at end of period $ 32,569 $ 11,273